Search CDMOs

• AAV Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Charles River provides discovery, development, and manufacturing services across the drug development continuum, including cell and gene therapy capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.

• AAV Manufacturing
• CMC Analytical Development
• Cell-Line Development

Creative Biogene provides viral vector manufacturing, cell line development, and RNA therapeutic platforms including AAV, lentivirus, adenovirus production, circular RNA synthesis, and lipid nanoparticle formulation for gene therapy and vaccine applications.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

Creative Biolabs provides custom recombinant antibody production, high-throughput antibody screening, GMP antibody manufacturing, and antibody biosimilar development services for biomedical research and therapeutic development.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Cell-Line Development

Cellistic is an iPSC-focused CDMO offering integrated cell line development, process development, and GMP manufacturing for allogeneic cell therapy and regenerative medicine programs. The company operates a purpose-built, EMA-certified and FDA/PMDA-compliant manufacturing facility in Belgium.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

U.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.